Search research articles
Contact Us
Filters
Showing results (41-50 of 227) with videos related to
Page
of 23
Sort By:
Trends in Immunology
|
July 7, 2020
Rewriting History: Epigenetic Reprogramming of CD8<sup>+</sup> T Cell Differentiation to Enhance Immunotherapy
Caitlin C Zebley, Stephen Gottschalk, Ben Youngblood
Leukemia & Lymphoma
|
December 29, 2004
Adoptive immunotherapy for EBV-associated malignancies
Stephen Gottschalk, Helen E Heslop, Cliona M Rooney
Annual Review of Medicine
|
January 22, 2005
Post-transplant lymphoproliferative disorders
Stephen Gottschalk, Cliona M Rooney, Helen E Heslop
Blood
|
November 10, 2017
Redirecting T cells to hematological malignancies with bispecific antibodies
Mireya Paulina Velasquez, Challice L Bonifant, Stephen Gottschalk
Immunotherapy
|
September 30, 2010
Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation
Donald R Shaffer, Cliona M Rooney, Stephen Gottschalk
Advances in Cancer Research
|
March 9, 2002
Treatment of Epstein-Barr virus-associated malignancies with specific T cells
Stephen Gottschalk, Helen E Heslop, Cliona M Roon
Expert Opinion on Biological Therapy
|
September 26, 2017
Advances in immunotherapy for pediatric acute myeloid leukemia
Challice L Bonifant, Mireya Paulina Velasquez, Stephen Gottschalk
Frontiers in Immunology
|
January 25, 2021
Allogeneic CAR Cell Therapy-More Than a Pipe Dream
Kenneth J Caldwell, Stephen Gottschalk, Aimee C Talleur
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 26, 2020
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Current Topics in Microbiology and Immunology
|
May 27, 2026
Adoptive T-Cell Immunotherapy
Stephen Gottschalk, Catherine M Bollard, Cliona M Rooney
Page
of 23
Search research articles
Search
Showing results (41-50 of 227) with videos related to
Sort By:
Page
of 23
Trends in Immunology
|
July 7, 2020
Rewriting History: Epigenetic Reprogramming of CD8<sup>+</sup> T Cell Differentiation to Enhance Immunotherapy
Caitlin C Zebley, Stephen Gottschalk, Ben Youngblood
Leukemia & Lymphoma
|
December 29, 2004
Adoptive immunotherapy for EBV-associated malignancies
Stephen Gottschalk, Helen E Heslop, Cliona M Rooney
Annual Review of Medicine
|
January 22, 2005
Post-transplant lymphoproliferative disorders
Stephen Gottschalk, Cliona M Rooney, Helen E Heslop
Blood
|
November 10, 2017
Redirecting T cells to hematological malignancies with bispecific antibodies
Mireya Paulina Velasquez, Challice L Bonifant, Stephen Gottschalk
Immunotherapy
|
September 30, 2010
Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation
Donald R Shaffer, Cliona M Rooney, Stephen Gottschalk
Advances in Cancer Research
|
March 9, 2002
Treatment of Epstein-Barr virus-associated malignancies with specific T cells
Stephen Gottschalk, Helen E Heslop, Cliona M Roon
Expert Opinion on Biological Therapy
|
September 26, 2017
Advances in immunotherapy for pediatric acute myeloid leukemia
Challice L Bonifant, Mireya Paulina Velasquez, Stephen Gottschalk
Frontiers in Immunology
|
January 25, 2021
Allogeneic CAR Cell Therapy-More Than a Pipe Dream
Kenneth J Caldwell, Stephen Gottschalk, Aimee C Talleur
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 26, 2020
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Current Topics in Microbiology and Immunology
|
May 27, 2026
Adoptive T-Cell Immunotherapy
Stephen Gottschalk, Catherine M Bollard, Cliona M Rooney
Page
of 23